The 2024 Naltrexone Symposium
Thirty years ago, naltrexone was approved by the FDA for the treatment of alcohol dependence. Last month, researchers, clinicians, and patients gathered in Pennsylvania to commemorate the anniversary, share insights, and plan for the next 30 years of naltrexone’s adoption.
Oar’s team was proud to proud to share the work that we are doing to increase access to naltrexone through telehealth and to highlight the results our members are achieving, including:
76% drinking less within two weeks
65% meeting their goal often or always whether it is to drink less or quit
75% achieving health and wellness benefits
Across the diverse group of attendees, there was a strong consensus on several points:
— Naltrexone is a safe and effective tool for helping people to drink less or quit
— Naltrexone is dramatically under-prescribed with only 2% of people with alcohol use disorder being prescribed
any medication that can help them drink less or quit
— There are multiple effective ways to use naltrexone:
once daily, targeted to drinking occasions as in
The Sinclair Method, or via longer-acting
Vivitrol injection
— We are making progress: more naltrexone prescriptions being written, more access points becoming available, and more patients self-organizing to support each other on
Reddit, through free meet-ups like
TSMMeetups, and through programs like
Thrive
— We must work together to help everyone who can benefit from naltrexone learn about the medication and get access to it.
The Naltrexone Alliance, founded this year, will be working to increase awareness, advocate for adoption, improve accessibility, research best practices, and optimize treatment recommendations.
If you would like to join the The Naltrexone Alliance,
sign up here.